Dogwood Therapeutics Inc (DWTX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2024 | 12-2023 | 12-2022 | 12-2021 | 12-2020 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 14,848 | 3,317 | 7,031 | 14,008 | 29,795 |
| TOTAL | $16,545 | $4,165 | $8,370 | $15,777 | $31,473 |
| Non-Current Assets | |||||
| PPE Net | 17 | N/A | N/A | N/A | N/A |
| Intangibles | 77,523 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets | 224 | 0 | 0 | 0 | 0 |
| TOTAL | $77,764 | $N/A | $N/A | $N/A | $N/A |
| Total Assets | $94,308 | $4,165 | $8,370 | $15,777 | $31,473 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 1,232 | 112 | 573 | 354 | 369 |
| Accrued Expenses | 1,895 | 247 | 470 | 922 | 1,163 |
| TOTAL | $3,176 | $359 | $1,043 | $1,276 | $1,532 |
| Non-Current Liabilities | |||||
| Long Term Debt | 15,381 | N/A | N/A | N/A | N/A |
| Other Non-Current Liabilities | 155 | 0 | 0 | 0 | 0 |
| TOTAL | $26,851 | $N/A | $N/A | $N/A | $N/A |
| Total Liabilities | $30,027 | $359 | $1,043 | $1,276 | $1,532 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 1,911 | 770 | 733 | 333 | N/A |
| Common Shares | 0 | 0 | 2 | 1 | 1 |
| Retained earnings | -73,819 | -61,469 | -56,173 | -43,925 | -27,965 |
| Other shareholders' equity | 70,243 | -299 | 0 | 0 | 0 |
| TOTAL | $64,281 | $3,807 | $7,327 | $14,501 | $29,941 |
| Total Liabilities And Equity | $94,308 | $4,165 | $8,370 | $15,777 | $31,473 |